F.D.A. Seeks Investigation of Its Own Alzheimer ’s Drug Approval

The agency ’s acting head said a review should look into whether any interactions between agency staff and the drug developer, Biogen, broke F.D.A. rules.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Aduhelm (Drug) Alzheimer ' s Disease Drugs (Pharmaceuticals) Inspectors General Biogen Inc Food and Drug Administration Woodcock, Janet Source Type: news